A healthy intestine is in a chronic state of low grade inflammation. The epithelial cells and the lamina propria are full of immune cells, abnormally high number of immune cells compared to other tissue in the body, indicating the intestine is a highly stressed organ.
Millions of naive immune cells originate in the thymus, travel through the bloodstream, end up in peyer's patches in the ileum and intestinal tissue. Many more are recruited when dendritic cells come into contact with antigen. That antigen comes from bacteria and the fecal stream.
These armies of immune cells are all triggered by bacteria or food antigen. The fecal stream is full of bacteria and food antigen. Using FMT to try to treat crohn's disease is like taking gasoline and throwing it on a fire.
That's why these FMT studies had crohn's disease studies where calpro jumped and they needed immediate escalation of anti-inflammatories. FMT is no longer pursued for crohn's disease, a good thing, because they would have eventually killed patients due to bacteremia. People with crohn's disease have deep transmural inflammation, granuloma where immune cells try to wall off fecal content. The last thing you want to do is expose these people to a FMT. It's dangerous, and it was highly predictable that this would not work and would cause adverse effects.
FMT does not work and harms patients. Doctors still doing this to patients need to be in jail, it is malpractice.
"21 and 13 patients were randomized to FMT and placebo groups, respectively. The trial terminated early due to futility. At week 8, 0% (0/15) of patients in the FMT group versus 8.3% (1/11) in the placebo group reached the primary end point of combined clinical and endoscopic remission as per protocol analysis."
https://journals.lww.com/ajg/fullte...ults_from_a_multicenter,_randomized.1438.aspx
"10 CD patients underwent FMT and were evaluated for clinical response and microbiomeprofile at one month post-FMT. There was no significant improvement in objective measures of inflammation such as fecal calprotectin and SES CD score. Single-dose FMT in this cohort of CD patients showed modest effect and potential for harm."
https://onlinelibrary.wiley.com/doi/10.1177/2050640619845986